cohort of patients hospitalized in the ICU of a single large medical center.
METHODS

Study Population
We used the Multiparameter Intelligent Monitoring in Intensive Care (MIMIC-III) database, a joint venture managed by the Laboratory for Computational Physiology at Massachusetts Institute of Technology (MIT) and the Department of Medicine at the Beth Israel Deaconess Medical Center (BIDMC) (21) . MIMIC-III contains data from 37,305 unique adult critical care admissions between 2001 and 2012 at BIDMC, a 700-bed urban academic medical center with 77 adult ICU beds. The database contains high-temporal-resolution data from clinical systems, including laboratory results, electronic documentation, and bedside monitor trends and waveforms. Use of the MIMIC II database has been approved by the Institutional Review Boards of BIDMC and MIT.
A total of 22,073 individuals had a documented height within the BIDMC electronic medical record. Of these, 18,938 had a documented weight upon ICU admission, allowing calculation of BMI. After exclusion of 743 end-stage renal disease patients, 17,140 had documentation of renal function. To identify comorbidities and medication exposure, we included the 15,470 patients with an admission history and physical examination with admission medication lists. Of these, 484 were missing documentation of admission ICU vitals, leaving a primary complete case analysis of 14,986.
Outcomes
The primary outcome was acute kidney injury during ICU admission, as defined by either a greater than or equal to 0.3 mg/dL increase within 48 hours or a greater than or equal to 50% increase within 7 days of ICU admission, or acute dialysis, in keeping with the Kidney Disease Outcome Quality Initiative guidelines (22) . We also explored the association of BMI with severity of AKI. Stage I AKI was defined as 50-100% increase in admission serum creatinine within 7 days, stage II as greater than 100-200% increase, and stage III as greater than 200% increase, or the initiation of acute dialysis. Following best practice guidelines, we used the admission creatinine to define "baseline" (23) .
To evaluate risk of death during hospitalization and within 1 year from hospital discharge, we linked medical records to the Social Security Death Index.
Exposure
BMI was the primary exposure, categorized in standard World Health Organization groupings: less than 18.5 (underweight), greater than or equal to 18.5 to less than 25 (normal), greater than or equal to 25 to less than 30 (overweight), greater than or equal to 30 to less than 35 (class I obesity), greater than or equal to 35 to less than 40 (class II obesity), and BMI greater than or equal to 40 (class III obesity), and as a continuous variable per 5 units of BMI.
Because weight at the time of critical illness might not reflect usual body weight, we performed a validation study among 150 randomly selected subjects within the dataset to determine body weights measurements obtained during noncritical illness. A total of 86 individuals had documented weights during noncritical illness in the electronic medical record. The Spearman correlation coefficient between ICU and non-ICU body weights measurements was 0.93 (p < 0.001), with a median difference of -0.03 kg (interquartile range, -2.8 to 2.9).
Covariates
Demographic information included age, sex, and race, coded as white, African-American, Asian, Hispanic, other, or unknown. We identified patients with heart failure through Natural Language Processing searching of the Past Medical History section of the admission examination or Elixhauser discharge coding (24) . We also used oral diabetes medication or insulin usage, along with Elixhauser discharge coding, to identify diabetic patients. All additional Elixhauser discharge coding comorbidities except for "acute renal failure" and "obesity" were included as separate variables (24) . ICU types included cardiac, surgical, cardiothoracic, and medical units. Sequential Organ Failure Assessment scores were used to indicate severity of illness. Because of the effect of hemodynamics on renal function, we also included systolic and diastolic blood pressure, heart rate, and temperature as independent variables. Admission creatinine, defined as the first available creatinine 24 hours prior to, or 6 hours after, ICU admission, was used as a determinant of "baseline" kidney function. Admission hemoglobin was also included. Because obesity is likely associated with increased diuretic, angiotensin-converting enzyme inhibitor (ACE-I), angiotensin-receptor blocker (ARB), and statin usage, we used Natural Language Processing searches of prehospital medication lists to identify these exposures. All admission values, except for creatinine, were taken from the first available laboratory data within 24 hours of ICU admission.
Statistical Analysis
We present descriptive baseline characteristics stratified by BMI. We used logistic regression to examine the association between BMI, defined categorically and continuously, and odds of AKI, based on serum creatinine changes. We adjusted for age, gender, race, ICU type, Sequential Organ Failure Assessment score, history of diabetes, congestive heart failure, hypertension, chronic obstructive pulmonary disease, peripheral vascular disease and 22 additional Elixhauser comorbidities, admission systolic and diastolic blood pressure, heart rate, temperature, creatinine and hemoglobin, and preillness diuretic, ACE-I, ARB, or statin use.
We describe the prevalence of AKI stages I to III per BMI classification. We used ordinal logistic regression to describe the adjusted risk of a one-step increase of AKI severity with an increase of BMI. In separate logistic regressions, we then examined the risk of having either stage II or III AKI when compared with that of having either no AKI or stage I AKI and the risk of having stage III AKI when compared with that of having no AKI, stage I, or stage II AKI.
To contextualize the clinical significance of an episode of AKI in obesity, we used logistic regression to define the adjusted risk of an episode of AKI on within-hospital mortality within each BMI category. We also describe the effect of AKI on long-term survival according to BMI in hospital survivors. We used Cox regression analyses, censoring those who survived 365 days or more, and adjusting for the same variables as above, within each BMI category.
In sensitivity analyses, to further explore potential mechanisms for the observed strong association of increasing BMI with risk of AKI, we performed sequential logistic regressions examining how the addition of admission proteinuria, defined as trace or greater on urinary dipstick measurement, and admission central venous pressure (CVP), obtained within the first 6 hours of admission, changed the association of BMI with AKI. In addition, we used creatinine measurements obtained prior to 7 days from ICU admission as "baseline" in 7,000 patients with available measurements. For all analyses, normal weight was considered the reference category. All analyses were performed using JMP Pro (SAS Institute, Cary, NC).
RESUlTS baseline Characteristics
Of 14,986 critically ill patients admitted to a medical or surgical ICU with available data, 431 (3%) were underweight, 4,271 (28%) were normal weight, 5,047 (34%) were overweight, 2,908 (19%) had class I obesity, 1,292 (9%) had class II obesity, and 1,037 (7%) had class III obesity. Obesity was associated with a higher prevalence of heart failure, hypertension, and diabetes than those with normal BMIs, and greater exposure to diuretics, ACE-Is, ARBs, and statins prior to admission ( Table 1) . Admission blood pressure tended to be similar across BMI categories. Admission creatinines tended to be higher in obese patients.
bMI and Prevalence and Severity of AKI
During the course of critical illness, 3,122 (21.1%) individuals developed AKI. As seen in Table 2 , the prevalence and adjusted risk of AKI progressively increased with higher BMI. Each 5-kg/m 2 increment in admission BMI was associated with a 10% (95% CI, 1.06-1.24; p < 0.001) higher adjusted risk of AKI in a model that accounted for demographics, comorbidities, severity of critical illness, medication exposure, and admission creatinine. As a frame of reference, diabetes was associated with a 1.26 (95% CI, 1.15-1.38; p < 0.001) higher risk of AKI.
The prevalence of AKI severity according to BMI is illustrated in Figure 1 . In adjusted analysis, a 5-kg/m 2 increment was associated with a 9% higher risk (95% CI, 1.06-1.22; p < 0.001) of having a higher stage of AKI. As seen in Table 3 , the risk of having stage II or III AKI, when compared with that of having either no AKI or stage I AKI, or stage III AKI, compared with that of having no AKI, stage I, or stage II AKI, increased progressively with higher BMI relative to normal weight patients.
AKI and Survival
There were 1,513 (10%) deaths during the critical illness hospitalization. The association of AKI with in-hospital mortality was modified by BMI (multiplicative interaction term p < 0.01). When stratified by BMI category, AKI was consistently associated with a significantly higher risk of death (Table 4) . When stratified by AKI, a protective effect of obesity on hospital survival was observed in those without AKI, as has previously been reported. A 5-kg/m 2 BMI increase was associated with a 0.89 (95% CI, 0.85-0.94; p < 0.001) odds ratio (OR) of within-hospital death in those without AKI. However, in those with AKI, each 5-kg/m 2 BMI increase was associated with a 0.98 (95% CI, 0.96-1.09; p = 0.59) risk of within-hospital death.
Among 13,473 hospital survivors, 1,568 (12%) died within 1 year of hospital discharge. The association of AKI with subsequent 1-year mortality was not modified by BMI (multiplicative interaction term, 0.43). Similarly, an episode of AKI during critical illness was associated an increased risk of dying within the following 1 year across BMI categories (Table 4) .
Sensitivity Analyses
Among patients with available data, CVP (n = 4,017) and prevalence of admission proteinuria (n = 5,753) increased progressively with higher BMI (Fig. 2) . Addition of CVP into the multivariateadjusted model reduced the OR minimally (OR, 1.08; 95% CI, 1.02-1.14; p = 0.003, per 5-kg/m 2 BMI increase), and in 2,116 participant with both measurements, each 5-kg/m 2 increment was associated with a 1.08 (95% CI, 1.01-1.16; p = 0.03) increased risk of AKI.
Defining baseline renal function by a serum creatinine obtained more than 7 days prior to critical illness, rather than by the admission creatinine, did not meaningfully change the association between BMI and AKI. In 7,891 patients with available preillness serum creatinine measurements, the correlation between preillness and admission serum creatinine measurements was 0.68 (p < 0.001). Each 5-kg/m 2 increment remained associated with a 1.08 (95% CI, 1.01-1.16; p = 0.02) increased risk of AKI.
DISCUSSION
Our findings highlight obesity as a risk factor for AKI during critical illness. In models that adjusted for comorbidities, acuity of illness, preillness ACE, ARB, and diuretic use, each 5 kg/m 2 was associated with a 10% increased risk of AKI. Furthermore, these episodes of AKI were associated with worse short-and long-term survival.
Our findings supplement a growing awareness of the susceptibility to AKI in obesity. In a recent study of almost 500 critically ill patients with acute respiratory distress, each 5-kg/m 2 increase in BMI was associated with a 20% increased risk of AKI (15) . In a large Austrian study, severely obese patients had a greater than two-fold increased risk of severe AKI than normal-weighted patients (16) . Long-term survival was not available in either study. More recent studies, however, have not identified obesity as a significant risk factor for AKI (7) .
Our observed association between obesity and AKI raise questions about potential pathophysiologic mechanisms (25) . The hemodynamic perturbations associated with obesity could explain an increased susceptibility (26) . Cor pulmonale, a result of hypoventilation, sleep apnea, and pulmonary hypertension, occurs frequently in obesity (27, 28) and leads to sodium avidity and peripheral venous congestion. Patients with obesity have higher right-sided filling pressures (29) and greater diuretic requirements (30) than those with normal weight. The role of venous congestion as a determinant of renal function has been known for over 80 years, with early physiology experiments highlighting that increased renal venous pressures decreased urine formation (31, 32) . More recent clinical data have focused on peripheral venous congestion in heart failure (33), where CVPs, but not cardiac output or pulmonary artery pressures, are associated with renal dysfunction, highlighting the importance of the transrenal pressure gradient, a balance between renal arterial perfusion and venous drainage, as a determinant of renal function. Similarly, increasing CVP has been associated with AKI in sepsis (34) .
In our analysis, increasing BMI was associated with higher CVPs obtained within 6 hours to the ICU. However, inclusion of CVP measures did not significantly attenuate or modify the association between BMI and AKI, suggesting that additional factors may exist.
Recent data have highlighted organ-specific abnormalities in obesity, with changes seen both within the kidney and the heart. Obesity leads to renal glomerular hypertrophy and hyperfiltration (35) , which potentially contribute to renal susceptibility. More recently, an "adipose-renal" hormonal axis has emerged. Adiponectin, an insulin-sensitizing hormone that regulates glucose and lipid metabolism, and which is markedly decreased in visceral obesity, is protective in some models of renal ischemia reperfusion injury although considered pathogenic in others (36) . Leptin, an adipocyte-derived cytokine that is metabolized in the kidney and controls energy metabolism and appetite modulates susceptibility to endotoxin-mediated renal failure and stimulates proliferation and fibrosis (37, 38) . Autophagy, an important internal degradation system whereby cells can remove damaged proteins and organelles, is impaired in obesity (1). Cardiac changes associated with obesity also might affect renal perfusion. In addition to increased left ventricular hypertrophy, direct infiltration of the myocardium has been reported, termed "cardiomyopathy of obesity" (39) (40) (41) . Thus, whether kidney or cardiac-specific changes associated with obesity contribute to the prevalence of AKI is plausible. In addition to establishing obesity as a risk for AKI, our data highlight the associated short-and long-term outcomes associated with AKI. In our analysis, even though patients with obesity were more likely to develop AKI, these AKI episodes were not less significant. Rather, across BMI categories, AKI was associated with increased within-hospital mortality and 1-year mortality. In addition, whereas obesity has paradoxically been associated with an improved prognosis in critical illness, this protective association is absent in patients with AKI. Whether renal protective strategies, including minimizing radiographic contrast and potentially nephrotoxic medications, careful use of diuretics, and careful blood pressure management to minimize hypotension, might improve outcomes, remains speculative. limitations Although our study had a number of strengths, including an extremely large dataset with ample power and systematic assessment of mortality, the observational nature of our analysis limits any conclusions of causality. Furthermore, although the large number of patients and the multiple covariates allow for adjustment, it is plausible that confounding remains. Given the unaccounted effect of critical illness on weight, and the lack of information about weight changes prior to admission, confounding due to malnutrition, cachexia, and fluid retention likely remains although we would not expect nonadipose contributors to BMI such as fluid retention to be associated with improved 1-year mortality. In addition, our manual review of randomly selected charts suggests a strong correlation between critical and noncritical illness BMI values. In addition, we used admission serum creatinines to account for baseline function, which likely leads to misclassification. However, in a subset of patients with available creatinine measurements prior to critical illness, admission and baseline creatinines were highly correlated, and the association of BMI with AKI remained robust. Furthermore, because the baseline serum creatinine may be increased in obesity, our outcome of a 
